featured
Another Option in the Treatment of Advanced Gastric Adenocarcinoma?
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Ramucirumab Adds to Efficacy of Chemotherapy in Advanced Gastric Cancer
- Ramucirumab Monotherapy for Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma (REGARD): An International, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial
- A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2 in Patients With Advanced Hepatocellular Cancer
Disclosure statements are available on the authors' profiles: